(Q74812578)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

1 reference

L C Altman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Z Munk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

J Seltzer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

N Noonan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

S Shingo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

J Zhang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

T F Reiss

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Allergy and Clinical Immunology

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

50-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

Leukotrienes are potent constrictors of human bronchi

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

The effect of synthetic leukotrienes on tracheal microvascular permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Leukotrienes and airway responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Testing the statistical certainty of a response to increasing doses of a drug

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

High-dose inhaled steroid therapy for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Do leukotrienes play a role in the regulation of proliferation of normal and leukemic hemopoietic cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

Leukotriene E4 and granulocytic infiltration into asthmatic airways

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970054-5

7 January 2021

10.1016/S0091-6749(98)70054-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679847%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference